(NVAX:Consolidated Issue Listed on NASDAQ Global Select )
James F. Young Ph.D.
Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee, Novavax, Inc.
|Age||Total Calculated Compensation||This person is connected to 50 board members in 4 different organizations across 6 different industries.|
See Board Relationships
Dr. James F. Young, also known as Jim, Ph.D., is a Professor and Chairman, Academic Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Chairman, Endocrinology and Metabolism Institute. Dr. Young also serves as a Physician Director of Institutional Relations and Development and a Medical Director of the Kaufman Center for Heart Failure. Dr. Young served as the President, Research and Development of MedImmune LLC ...
20 Firstfield RoadPhone: 240-268-2000
Gaithersburg, Maryland 20878
Board Members Memberships*
Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Chairman of the Board
Baylor College of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|J. Joseph Kim Ph.D.||Chief Executive Officer, President, Director and Member of Finance Committee|
Inovio Pharmaceuticals, Inc.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|Anthony S. Marucci M.B.A.||Chief Executive Officer, President and Director|
Celldex Therapeutics, Inc.
|Jonathan J. Lewis M.D., Ph.D.||Chief Executive Officer and Director|
ZIOPHARM Oncology, Inc.
|$600.0K||Compensation as of Fiscal Year 2014.|